Géraldine Gelders

1.4k total citations · 1 hit paper
7 papers, 838 citations indexed

About

Géraldine Gelders is a scholar working on Neurology, Neurology and Physiology. According to data from OpenAlex, Géraldine Gelders has authored 7 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 4 papers in Neurology and 4 papers in Physiology. Recurrent topics in Géraldine Gelders's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Géraldine Gelders is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Géraldine Gelders collaborates with scholars based in Belgium, United Kingdom and United States. Géraldine Gelders's co-authors include Veerle Baekelandt, Anke Van der Perren, Chris Van den Haute, Wouter Peelaerts, Ronald Melki, Luc Bousset, Alexis Fenyi, Steve Gentleman, Sarah van Veen and Shaun Martin and has published in prestigious journals such as Nature, Brain and Acta Neuropathologica.

In The Last Decade

Géraldine Gelders

7 papers receiving 830 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease

2018 347 citations Géraldine Gelders, Veerle Baekelandt et al. Journal of Immunology Research profile →

Peers

Countries citing papers authored by Géraldine Gelders

Since Specialization

Citations

This map shows the geographic impact of Géraldine Gelders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Gelders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Gelders more than expected).

Fields of papers citing papers by Géraldine Gelders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Gelders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Gelders. The network helps show where Géraldine Gelders may publish in the future.

Co-authorship network of co-authors of Géraldine Gelders

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Gelders. A scholar is included among the top collaborators of Géraldine Gelders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Gelders. Géraldine Gelders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy 2022 ·Brain ·(unknown), Anke Van der Perren, Audrey Coens, Géraldine Gelders, (unknown), (unknown), Therése Klingstedt, Peter Nilsson, Nadia Stefanova, Ronald Melki, Veerle Baekelandt, Wouter Peelaerts	13
2	LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo 2021 ·Neurotherapeutics ·Anke Van der Perren, (unknown), Géraldine Gelders, Javier María Peralta Ramos, Chris Van den Haute, Veerle Baekelandt, Evy Lobbestael	12
3	The AppNL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research 2021 ·Acta Neuropathologica Communications ·(unknown), (unknown), Sophie Lemmens, Xavier Hadoux, Géraldine Gelders, (unknown), Lutgarde Serneels, Jan Theunis, Takashi Saito, Takaomi C. Saido, Murali Jayapala, Patrick De Boever, Bart De Strooper, Ingeborg Stalmans, Peter van Wijngaarden, Lieve Moons, Lies De Groef	34
4	ATP13A2 deficiency disrupts lysosomal polyamine export 2020 ·Nature ·Sarah van Veen, Shaun Martin, Chris Van den Haute, Veronick Benoy, Joseph A. Lyons, Roeland Vanhoutte, Jan Kähler, Jean-Paul Decuypere, Géraldine Gelders, Eric J. Lambie, Jeffrey Zielich, Johannes V. Swinnen, Wim Annaert, Patrizia Agostinis, Bart Ghesquière, Steven H. L. Verhelst, Veerle Baekelandt, Jan Eggermont, Peter Vangheluwe	216
5	The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies 2020 ·Acta Neuropathologica ·Anke Van der Perren, Géraldine Gelders, Alexis Fenyi, Luc Bousset, (unknown), Wouter Peelaerts, Chris Van den Haute, Steve Gentleman, Ronald Melki, Veerle Baekelandt	171
6	Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export 2020 ·Acta Neuropathologica ·Shaun Martin, (unknown), Chris Van den Haute, Bavo Heeman, Sarah van Veen, David Crosiers, (unknown), Aline Verstraeten, (unknown), Géraldine Gelders, Philippe Pals, (unknown), Sebastiaan Engelborghs, Jean‐Jacques Martin, Jan Eggermont, Peter Paul De Deyn, Patrick Cras, Veerle Baekelandt, Peter Vangheluwe, Christine Van Broeckhoven	45
7	Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease breakdown → 2018 ·Journal of Immunology Research ·Géraldine Gelders, Veerle Baekelandt, Anke Van der Perren	347

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact